1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene

Names

[ Name ]:
1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene

[Synonym ]:
MFCD07781991
1,3-Bis(2,6-diisopropylphenyl)-2,3-dihydro-1H-imidazole
1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidene
2H-imidazol-2-ylidene, 1,3-bis[2,6-bis(1-methylethyl)phenyl]-1,3-dihydro-
1H-Imidazole, 1,3-bis[2,6-bis(1-methylethyl)phenyl]-2,3-dihydro-
1,3-Bis(2,6-diisopropylphenyl)iMidazol-2-ylidene
1,3-Bis(2,6-diisopropylphenyl)-1H-imidazol-3-ium-2-ide

Chemical & Physical Properties

[ Density]:
1.0±0.1 g/cm3

[ Boiling Point ]:
464.8±45.0 °C at 760 mmHg

[ Melting Point ]:
213-217ºC

[ Molecular Formula ]:
C₂₇H₃₈N₂

[ Molecular Weight ]:
390.604

[ Flash Point ]:
204.1±16.5 °C

[ Exact Mass ]:
390.303497

[ PSA ]:
6.48000

[ LogP ]:
7.78

[ Appearance of Characters ]:
Powder | white to off-white

[ Vapour Pressure ]:
0.0±1.1 mmHg at 25°C

[ Index of Refraction ]:
1.556

[ Storage condition ]:
?20°C

MSDS

Click to get detail MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Risk Phrases ]:
R10

[ Safety Phrases ]:
S16

[ RIDADR ]:
UN 1325

[ HS Code ]:
29332900

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

DownStream

Articles

An air-stable palladium/N-heterocyclic carbene complex and its reactivity in aryl amination.

Org. Lett. 4 , 2229, (2002)

[reaction: see text] The synthesis and characterization of [Pd(IPr)Cl(2)](2) (1), an air- and moisture-stable complex, is reported. The utilization of 1 as a catalyst for amination of aryl chlorides a...

The anti-DNA antibody: origin and impact, dogmas and controversies.

Nat. Rev. Rheumatol. 11 , 530-40, (2015)

The inclusion of 'the anti-DNA antibody' by the ACR and the Systemic Lupus International Collaborating Clinics (SLICC) as a criterion for systemic lupus erythematosus does not convey the diverse origi...

Effects of Fetal and Neonatal Murine Peripheral Blood Mononuclear Cells Infusion on MicroRNA-145 Expression in Renal Vascular Smooth Muscle Cells in MRL/lpr Mice.

Transplant. Proc. 47 , 2523-7, (2015)

For patients with refractory systemic lupus erythematosus, current medications are insufficient to control their condition, and new treatments are necessary. We aimed to evaluate the therapeutic effec...